Helmut Jeggle
Supervisory Board
BioNTech
Germany
Biography
Helmut Jeggle is responsible for the life science initiatives of the Strüngmann brothers. Previously, he was the Head of Business Planning & Analyses at Hexal AG and is currently member of numerous Supervisory Boards. Hexal was sold to Novartis in 2005 for $8.3bn in cash. He has a degree in business administration from the FH Neu-Ulm and earned his MBA from the Stuttgart Institute of Management and Technology (SIMT) during his time at Hexal.
Research Interest
Business Development
